×
Organon Total Liabilities 2019-2024 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organon total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Organon Total Liabilities 2019-2024 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organon total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$98B
Cencora (COR)
$48.9B
DiDi Global (DIDIY)
$23.6B
ICON (ICLR)
$17.7B
Natera (NTRA)
$16.6B
Viatris (VTRS)
$15.5B
Avantor (AVTR)
$15.4B
Revvity (RVTY)
$14.9B
BioMerieux (BMXMF)
$13.1B
CochLear (CHEOY)
$12.6B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.3B
Charles River Laboratories (CRL)
$11B
Doximity (DOCS)
$10.8B
HealthEquity (HQY)
$8.6B
Sonic Healthcare (SKHHY)
$8.5B
Bausch + Lomb (BLCO)
$7B
Life Times (LTH)
$5.2B
Sotera Health (SHC)
$4.6B
Surgery Partners (SGRY)
$3.9B
BrightSpring Health Services (BTSG)
$3.4B
PACS (PACS)
$3.3B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B
Teladoc Health (TDOC)
$1.6B